Nurr1/NR4A2

Nurr1/NR4A2 is an orphan nuclear receptor required for the development and maintenance of midbrain dopaminergic neurons, with Nurr1-deficient mice failing to generate these neurons and adult Nurr1 loss reducing dopamine markers^[1][2]. Mechanistically, Nurr1 supports dopamine homeostasis by regulating genes linked to dopamine synthesis, storage, and reuptake, including TH, VMAT, DAT, and AADC^[3]. In neuroinflammatory Parkinson’s disease models, Nurr1 also represses NF-κB-dependent inflammatory gene expression in microglia and astrocytes through a Nurr1/CoREST pathway, thereby protecting dopaminergic neurons from inflammation-induced death^[4]. In immune disease models, NR4A2 promotes pathogenic T-cell cytokine production in MS/EAE but can also induce Foxp3 and suppress cytokines in CD4⁺ T-cell differentiation, showing context-dependent immune functions^[5][6]. Compared with related NR4A isoforms NR4A1/Nur77 and NR4A3/NOR1, NR4A2 shares family-level DNA-binding similarity but has a distinct, experimentally emphasized role in dopaminergic neuron maintenance and Nurr1-targeted neuroprotection^[2][7]. For experimental applications, Nurr1 agonists such as amodiaquine, chloroquine, glafenine, SA00025, C-DIM12, and 4A7C-301 provide chemical tools to activate Nurr1 transcriptional or anti-inflammatory functions in Parkinson’s disease and neuroinflammation models^{[3][8][9][10]}.